Kamal Hamed
Chief Tech/Sci/R&D Officer en SPERO THERAPEUTICS, INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Kamal Hamed is currently the Chief Medical Officer at Spero Therapeutics, Inc. Prior to this, he worked as the Chief Medical Officer at Lysovant Sciences, Inc. Hamed holds a graduate degree from The Johns Hopkins University, an MBA from the University of South Florida, and a doctorate from the American University of Beirut.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SPERO THERAPEUTICS, INC.
1.46% | 02/02/2024 | 788 117 ( 1.46% ) | 1 M $ | 31/03/2024 |
Cargos activos de Kamal Hamed
| Empresas | Cargo | Inicio |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 15/09/2022 |
Antiguos cargos conocidos de Kamal Hamed.
| Empresas | Cargo | Fin |
|---|---|---|
| Lysovant Sciences, Inc. | Chief Tech/Sci/R&D Officer | - |
Formación de Kamal Hamed.
| The Johns Hopkins University | Graduate Degree |
| University of South Florida | Masters Business Admin |
| American University of Beirut | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SPERO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
| Lysovant Sciences, Inc. |
- Bolsa de valores
- Insiders
- Kamal Hamed
